twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2005
vol. 107
 
Share:
Share:
abstract:
Original paper

Photodynamic­ therapy­ with­ verteporfin ­in ­treating­ the ­choroidal­ neovascularisation­ secondary­ to­ multifocal­ choroiditis

Andrzej Gębka
1
,
Krystyna Raczyńska
1
,
Ce­za­ry­ Cie­cha­now­ski
1
,
Ja­ro­sła­wa­ Kraj­ka­-La­uer­
1

  1. Katedra i Klinika Chorób Oczu Akademii Medycznej w Gdańsku
Klinika Oczna 2005, 107(1-3): 118-120
Online publish date: 2005/03/15
View full text Get citation
 
Apart from AMD and pathologic myopia the posterior uveitis is the most common pathology being the cause of secondary choroidal neovascularisation (CNV). For many years the method of choice in treating those pathologies was the theramal laser photocoagulation with obvious limitations in the cases of subfoveal CNV. The implementation of PDT modality to every day's clinical practice expanded the range of CNV treatment methods. The following case report shows the results of treating the CNV secondary to multifocal choroiditis with PDT. During the 6 months of follow-up period we consider PDT as an effective, safe modality in treating the CNV secondary to inflammation. In the result of single PDT therapy the VA improvement of 4 ETDRS lines and it's stabilization on the level of 20/25 with the decrease of metamorphopsia was gained.
keywords:

photodynamic therapy, PDT, chorioretinal neovascularisation, CNV, choroiditis

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.